The Royal Marsden Hospital NHS Foundation Trust

London SW3 6JJ

2 studies enrolling now · 3 studies all time

What they study most

Advanced Malignancies, Cutaneous Melanoma, Stage II, EGFR Exon 19 Deletion, EGFR L858R, Melanoma, Nonsquamous Non-small Cell Lung Cancer, Ovarian Cancer, T-cell Lymphoma

Studies at this site

• BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) — Recruiting now
• Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling